IOC Sample Clauses

IOC. The Intergovernmental Oceanographic Commission (IOC) was established to provide the Member States of the United Nations (UN) with an essential mechanism for global co-operation in the study of the oceans. In order to perform its vital cross- sectoral and cross-agency responsibilities and provide an efficient and effective mechanism for drawing on the expertise of the non-governmental scientific community, the Twenty-fourth Session of the General Conference in 1987 provided the IOC with functional autonomy within UNESCO. The basic mission of the IOC is defined in Article 2 of its statutes which states that ‘The purpose of the Commission is to promote international co-operation and to co-ordinate programmes in research, services and capacity building, in order to learn more about the nature and resources of the ocean and coastal areas and to apply that knowledge for the improvement of management, sustainable development, the protection of the marine environment, and the decision making processes of its Member States.’ Flanders hosts the IOC’s project office for the IODE programme on oceanographic data and information. That office is also the global hub for IOC’s capacity development activities. XXXX has been a major funder for IOC projects.
AutoNDA by SimpleDocs
IOC. This was discussed in Council of Min in 21, after it was decided that this question should be dealt on bilateral level between the States, and no official decision. Also mentioned during meeting with SEZ and MAU. Therefore we should not discuss this it is a political matter. Secretary of COI not competent to handle this matter.
IOC. This discussion can’t be solved during this meeting, promise the matter will be referred to IOC. Mauritius: Not acceptable. Chair asked MS for their views. Xxxx: Totally agree with M and IOC, PRSP issue, Mauritius is PRSP. Xxxx is right in saying this is governance structure, RCU, ERCU, Council of Ministers. Propose that M request is taken note. Next step will be discussed in ERCU will be discussed again and sent again to Council of Ministers. M: Suggested in be inserted in the plan and then sent to the Council of Ministers. Xxxx: Too early. IOC: M position is to remove the zone of dispute. M: Squared part to be removed, so it is no longer a zone of dispute. It doesn’t reproduce EEZ accurately. Without squared part, not a zone of dispute. Xxxx: Initially Chagos was not in the map. Chagos should not be a squared part .
IOC. This is a workshop of consultation, all comments, etc are welcome, we are not here to take decisions. Suggests we record all the observations, it is up to higher authorities to decide. Mauritius Has a problem. We are in a legal committee, to validate. How is this consistent with what he said. We amend, should the other body wixh to change they should. Next level will get instructions from... Are decisions taken today from draft content It is an agreement and creates binding obligations. Name is not a problematic matter. IOC: Legal workshop to record recommendations so we may ahve a final document. Not a meeting of validation because PRSP will validate that will validate all documents after this consultation?

Related to IOC

  • WHEXXXX xs xxxx of a plan of reorganization, RESTART PARTNERS II, L.P., a Delaware Limited Partnership ("Restart II"), may acquire an ownership interest in Elsinore Corporation ("Elsinore") or the Four Queens, Inc. ("FQI");

  • PRODUCT MANUFACTURER'S SUPPLIERS Only those dealers/distributors listed by the manufacturer will be considered authorized to act on behalf of the Product Manufacturer.

  • Vaccine Passports Pursuant to Texas Health and Safety Code, Section 161.0085(c), Contractor certifies that it does not require its customers to provide any documentation certifying the customer’s COVID-19 vaccination or post-transmission recovery on entry to, to gain access to, or to receive service from the Contractor’s business. Contractor acknowledges that such a vaccine or recovery requirement would make Contractor ineligible for a state-funded contract.

  • API If the Software offers integration capabilities via an API, your use of the API may be subject to additional costs or Sage specific policies and terms and conditions (which shall prevail in relation to your use of the API). You may not access or use the API in any way that could cause damage to us or the Software, or in contravention of any applicable laws. We reserve the right in our sole discretion, to: (i) update any API from time to time; (ii) place limitations around your use of any API; and (iii) deny you access to any API in the event of misuse by you or to otherwise protect our legitimate interests.

  • Hepatitis B Vaccine Where the Hospital identifies high risk areas where employees are exposed to Hepatitis B, the Hospital will provide, at no cost to the employees, a Hepatitis B vaccine.

  • Influenza Vaccine Upon recommendation of the Medical Officer of Health, all employees shall be required, on an annual basis to be vaccinated and or to take antiviral medication for influenza. If the costs of such medication are not covered by some other sources, the Employer will pay the cost for such medication. If the employee fails to take the required medication, she may be placed on an unpaid leave of absence during any influenza outbreak in the home until such time as the employee has been cleared by the public health or the Employer to return to the work environment. The only exception to this would be employees for whom taking the medication will result in the employee being physically ill to the extent that she cannot attend work. Upon written direction from the employee’s physician of such medical condition in consultation with the Employer’s physician, (if requested), the employee will be permitted to access their sick bank, if any, during any outbreak period. If there is a dispute between the physicians, the employee will be placed on unpaid leave. If the employee gets sick as a reaction to the drug and applies for WSIB the Employer will not oppose the application. If an employee is pregnant and her physician believes the pregnancy could be in jeopardy as a result of the influenza inoculation and/or the antiviral medication she shall be eligible for sick leave in circumstances where she is not allowed to attend at work as a result of an outbreak. This clause shall be interpreted in a manner consistent with the Ontario Human Rights Code.

  • Product Supply The Parties shall reasonably cooperate and assist each other in transferring ownership of Product drug product and/or Product drug substance (such material, CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH “[***]”. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO AN APPLICATION REQUESTING CONFIDENTIAL TREATMENT PURSUANT TO RULE 406 PROMULGATED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. collectively, the “Product Lots”) set forth in Exhibit A attached hereto as promptly as reasonably practicable following the Effective Date; provided, however, that neither Party shall be required to pay money to any Third Party, commence any litigation with, or offer or grant any accommodation (financial or otherwise) to any Third Party. Such Product Lots shall be delivered EXW (Ex Works) (Incoterms 2010) AMGEN, Thousand Oaks, California. Any expense for shipment shall be borne by AKERO (including any import or export duties or taxes). Subject to the terms of this Section 5.4 and Section 6.2 (Additional AMGEN Warranties), AMGEN transfers the Product Lots to AKERO “as is”, and makes no other representation to AKERO in connection therewith. The Parties have entered into a Quality Agreement substantially in the form attached hereto as Exhibit F, dated as of the date hereof, governing the quality of the Product Lots to be supplied pursuant to this Section 5.4. For the avoidance of doubt, Product Lots consisting of drug product as set forth in Exhibit A supplied pursuant to this Section 5.4 shall be labeled for their intended clinical use as set forth in Exhibit A and the labeling of any Product drug product manufactured after the Effective Date shall be the responsibility of AKERO. Except for the Licensed Materials and such Product Lots to be transferred to AKERO, AKERO shall be responsible for, and shall bear the cost of, obtaining (whether by manufacturing or causing to be manufactured) research, clinical and commercial supplies of the Product. From and after the Effective Date, AKERO shall be responsible for all costs and expenses in connection with the storage of, and any stability studies performed on, the Product Lots.

  • Originating Switched Access Detail Usage Data A category 1101XX record as defined in the EMI Telcordia Practice BR-010-200- 010.

  • Loop Provisioning Involving Integrated Digital Loop Carriers 2.6.1 Where EveryCall has requested an Unbundled Loop and BellSouth uses Integrated Digital Loop Carrier (IDLC) systems to provide the local service to the end user and BellSouth has a suitable alternate facility available, BellSouth will make such alternative facilities available to EveryCall. If a suitable alternative facility is not available, then to the extent it is technically feasible, BellSouth will implement one of the following alternative arrangements for EveryCall (e.g. hairpinning):

  • USOC SOMEC XXXXX Note: In addition to the OSS charges, applicable discounted service order and related discounted charges apply per the tariff.

Time is Money Join Law Insider Premium to draft better contracts faster.